Abionyx Pharma SA (ABNX) — Capital Reinvestment Ratio

Latest as of December 2022: 0.27x

Abionyx Pharma SA (ABNX) has a Capital Reinvestment Ratio of 0.27x as of December 2022, meaning it reinvests 0% of its operating cash flow (€214.00K) in capital expenditures (€57.00K). Check Abionyx Pharma SA tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.27x

Capex / Operating Cash Flow

Operating Cash Flow

€214.00K

EUR

Capital Expenditures

€57.00K

EUR

Data as of

Dec 2022

Most recent filing

Annual Capital Reinvestment Ratio for Abionyx Pharma SA (None–None)

Year-by-year Capital Reinvestment Ratio for Abionyx Pharma SA from None to None. See ABNX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow